THOMAS G. WIGGANS - 01 Feb 2023 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Issuer symbol
PRDS
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
03 Feb 2023, 15:36:31 UTC
Previous filing
27 Jan 2023
Next filing
12 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRDS Stock Option (Right to Buy) Award $0 +562,500 $0.000000 562,500 01 Feb 2023 Common Stock 562,500 $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 1st day of each month after the Grant Date (02/01/2023), subject to continued service relationship.